First Wave Bio

About:

First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).

Website: https://www.firstwavebio.com

Twitter/X: firstwavebio

Top Investors: Omega Funds

Description:

First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD). The solutions include a gut-restricted small molecule that can be formulated for either oral or rectal administration to treat ulcerative colitis among other IBDs, giving UC patients more accessible and cost-effective treatment.

Total Funding Amount:

$2.62M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2015-01-01

Founders:

Anthony Opipari, Gary Glick, Luigi Franchi

Number of Employees:

11-50

Last Funding Date:

2018-09-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai